Gut bacteria changes and psoriasis relapse after stopping biologic treatment
Treatments studied
Part of Infections, Skin clinical trials.
This study looks at how your gut bacteria (microbiome) might change when you stop your biologic treatment, and whether those changes are linked to a psoriasis flare-up. By participating, you'll help doctors understand why some people relapse and possibly improve future treatment plans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- Your psoriasis is in remission (well controlled) for at least 6 months.
- You have stopped your biologic treatment (like an IL-17 or IL-23 inhibitor) for 2 to 4 weeks.
- You don't have other skin conditions, liver disease, celiac disease, or a bacterial infection.
- You don't have a personal or family history of psoriatic arthritis or inflammatory bowel disease.
- Your BMI is between 18.5 and 35, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
This study tests whether adding a Mediterranean diet to your psoriasis treatment can improve your skin. You will be asked to follow a heart-healthy diet for several months while taking a new biologic medicine.
This study looks at the immune cells in skin samples from people with psoriasis who are being treated with an anti-IL-23 biologic. The goal is to understand why some areas of skin do not improve or why flares happen, which may help improve treatments.
This study looks at how gum disease (periodontitis) may be linked to psoriasis. By examining your mouth, the researchers hope to learn more about the connection, which could help improve care for people with both conditions.
This study looks at how blood sugar control (including diabetes) changes immune cells in the skin for people with moderate to severe plaque psoriasis. It may help researchers understand what drives psoriasis and how it could respond to future treatments.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.